Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis

Japanese Journal of Clinical Oncology

Volumn 39, Issue 8, 2009, Pages 509-513

  Ohyashiki, Junko H ^a   Hisatomi, Hisashi ^b   Shimizu, Syoko ^b   Sugaya, Maki ^b   Ohyashiki, Kazuma ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b SEIKEI UNIVERSITY   (Japan)

Author keywords

Janus kinase 2; Mutation; Polycythemia vera

Indexed keywords

JANUS KINASE 2; JAK2 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ERYTHROCYTOSIS; EXON; FEMALE; GENE MUTATION; HEMATOPOIESIS; HUMAN; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; AMINO ACID SEQUENCE; GENETICS; MALE; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; PATHOLOGY; POLYCYTHEMIA; PROGNOSIS; SURVIVAL RATE;

ADULT; ALLELES; AMINO ACID SEQUENCE; BASE SEQUENCE; EXONS; FEMALE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYCYTHEMIA; POLYCYTHEMIA VERA; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 68849120335     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp048     Document Type: Article

References (12)

1. Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 2007;356:459-68.
2. Martinez-Aviles L, Besses C, Alvarez-Larrán A, Cervantes F, Hernández-Boluda JC, Bellosillo B. JAK2 exon 12 mutations in patients with polycythemia vera or idiopathic erythrocytosis. Haematologica 2007;92:1717-8.
3. Pardanani A, Lasho TL, Finke C, Hanson CA, Tefferi A. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2 V617F-negative polycythemia vera. Leukemia 2007;21:1960-3.
4. Percy MJ, Scott LM, Erber WN, Harrison CN, Reilly JT, Jones FG, et al. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels. Haematologica 2007;92:1607-14.
5. Kouroupi E, Zoi K, Parquet N, Zoi C, Kiladjian JJ, Grigoraki V, et al. Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients. Br J Haematol 2008;142:676-9.
6. Butcher CM, Hahn U, To LB, Gecz J, Wilkins EJ, Scott HS, et al. Two novel JAK2 exon 12 mutations in JAK2-V617F-negative polycythemia vera patients. Leukemia 2008;22:870-3.
7. Li S, Kralovics R, De Libero G, Theocharides A, Gisslinger H, Skoda RC. Clonal heterogeneity in polycythemia vera patients with JAK2 exon 12 and JAK2-V617F mutations. Blood 2008;111: 3863-6.
8. Pietra D, Li S, Brisci A, Passamonti F, Rumi E, Theocharides A, et al. Somatic mutations of AK2 exon 12 in patients with JAK2(V617F)-negative myeloproliferative disorders. Blood 2008;111: 1686-9.
9. Jones AV, Cross NCP, White HE, Green AR, Scott LM. Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis. Haematologica 2008;93:1560-4.
10. Ohyashiki K, Kiguchi T, Ito Y, Gotoh A, Tauchi T, Miyazawa K, et al. Isolated erythrocythemia: A distinct entity or a sub-type of polycythemia vera? Jpn J Clin Oncol 2008;38:230-2.
11. Theocharides A, Passweg JR, Medinger M, Looser R, Li S, Hao-Shen H, et al. The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders. Haematologica 2008;93:1890-3.
12. Ohyashiki K, Hori K, Makino T, Ohyashiki JH. Automated JAK2V617F quantification using a magnetic filtration system and sequence-specific primer-single molecule fluorescence detection. Cancer Genet Cytogenet 2007;179:19-24.